Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Closure container for single dose disposable pharmaceutical delivery system

a disposable pharmaceutical and container technology, applied in the direction of medical devices, intravenous devices, medical devices, etc., can solve the problem that none of these attempts have been economically competitiv

Inactive Publication Date: 2007-11-08
SERATOUCH
View PDF29 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0013]The unit dose disposable pharmaceutical delivery system is formed as a generally flat envelope about the size of a credit card having a tear-away portion and a dispensing portion. The pharmaceutical is stored in a bladder and is dispensed through a needle that is stationary in relationship to the bladder. In other words, the needle is not moved to puncture the bladder, prior to dispensing of the pharmaceutical. This delivery system is used to make intradermal or subcutaneous injections and thus the exposed portion of the needle can be relatively short. This system has particular advantage for battlefield applications, mass immunizations in underdeveloped areas of the world, and other general medical applications currently being serviced by pre-filled syringes. The delivery system may also be helpful to numerous individuals that do not have formal medical training, such as for insulin injections and / or emergency epinephrine injections.

Problems solved by technology

Many attempts have been made to produce a single dose disposable pharmaceutical delivery system to replace conventional prefilled syringes; unfortunately none of these attempts have been economically competitive.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Closure container for single dose disposable pharmaceutical delivery system
  • Closure container for single dose disposable pharmaceutical delivery system
  • Closure container for single dose disposable pharmaceutical delivery system

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0020]This is a description of FIGS. 1-6 of the unit dose disposable pharmaceutical delivery system generally identified by the numeral 10. The delivery system 10 forms an envelope 12 which includes the tear-away portion 14 and the dispensing portion 16. A tear line 18 divides the tear-away portion 14 from the dispensing portion 16. To separate the two portions, the user merely tears and slightly rotates the tear-away portion from the dispensing portion.

[0021]The envelope 12 may be formed from an anterior sheet 20 and a posterior sheet 22. Depending on the application, other sheets may also be used, such as second anterior sheet 21 and second posterior sheet 23. Other sheets, not shown may also be necessary. The bladder 24 may be formed separately from the sheets 20 and 22 or it may be defined by the sheets 20 and 22. FIGS. 1-6 show the bladder 24 formed separately from sheets 20, 21, 22 and 23.

[0022]In the preferred embodiment, the bladder may be formed from a relatively stiff ante...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
lengthaaaaaaaaaa
pressureaaaaaaaaaa
flexibleaaaaaaaaaa
Login to View More

Abstract

The disposable unit dose pharmaceutical delivery system may be used by trained medical personnel for intradermal or subcutaneous injections in applications currently being serviced by conventional pre-filled syringes. The delivery system may also be used by personnel with little or no medical training for mass immunizations in underdeveloped parts of the world, insulin injections, and / or emergency epinephrine injections. The delivery system includes an envelope with a tear-away section and a dispensing section. When the tear-away section has been removed, a needle is exposed and is ready for insertion in the patient. The dispensing portion is squeezed between the thumb and forefinger to inject the pharmaceutical into the patient. The exterior surface of the envelope may be used for advertising by a pharmaceutical producer, a supplier or otherwise.

Description

CROSS REFERENCE [0001]Applicant claims benefit of provisional patent application No. 60 / 746,261 filed on May 3, 2006 entitled “SeraTouch”.BACKGROUND OF THE INVENTION[0002]This invention relates to closure containers for single dose disposable pharmaceutical delivery systems. The system has particular advantage for battlefield applications, mass immunizations in underdeveloped areas of the world and other general medical applications currently being serviced by pre-filled syringes.[0003]During World War II Squibb, now Bristol-Myers Squibb, developed the morphine Syrette® disposable present invention. It consisted of a small tube of morphine with an attached hypodermic needle. Medical personnel first had to break a seal with a small needle. The morphine was administered by piercing the patient's skin with the needle and then squeezing the tube.[0004]A number of prior art patents for a disposable single dose dispenser utilize a moveable needle to puncture the container holding the phar...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61M5/00
CPCA61M5/282A61M2005/312Y10T29/49826A61M5/286A61M5/3202A61M5/002A61M2207/00
Inventor KELLY, STEVEN DALEMCCULLOCH, JAMES STANLEY
Owner SERATOUCH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products